EX-10.17



 Exhibit 10.17 

PharMEDium Healthcare Holdings, Inc. Senior Executive Bonus Plan 

I. Purposes 
 The purposes
of the PharMEDium Healthcare Holdings, Inc. Senior Executive Bonus Plan (the “Plan”) are to retain and motivate certain executive officers of the Company or any of its Subsidiaries who have been designated by the Compensation
Committee (the “Committee”) to participate in the Plan by providing them with the opportunity to earn performance-based incentive payments. It is intended that all amounts payable to Participants who are “covered
employees” within the meaning of Section 162(m) of the Code will constitute “qualified performance-based compensation” within the meaning of the U.S. Treasury regulations promulgated thereunder, and the Plan and the terms of any
Awards hereunder shall be so interpreted and construed to the maximum extent possible. 
 II. Certain Definitions 

“Adjusted EBITDA” shall mean, for a Performance Period, net income (loss) before equity in earnings of unconsolidated
Subsidiaries, equity-based compensation expense, merger expenses, depreciation and amortization expenses, non-recurring charges, related party management fees, interest expense, loss on extinguishment of debt, noncash charges and non-cash losses,
expenses related to any equity offering realized gain (loss) on investments, restructuring charges and income tax expense (benefit). If Adjusted EBITDA is negative for a fiscal year that is included within a Performance Period of more than one
fiscal year, Adjusted EBITDA for purposes of this Plan shall be deemed to be zero for that fiscal year. 
 “Award” shall
mean any incentive payment made to a Participant pursuant to the Plan. 
 “Board” shall mean the Board of Directors of the
Company. 
 “Code” shall mean the Internal Revenue Code of 1986, as amended. 

“Committee” shall mean the Compensation Committee of the Board or such other committee or subcommittee designated by the
Board that satisfies any then applicable requirements of the principal national stock exchange on which the common stock of the Company is then traded to constitute a compensation committee, and which, as to any compensation intended to qualify as
performance-based compensation under Section 162(m) of the Code, shall consist of two or more members, each of whom is an “outside director” within the meaning of Section 162(m) of the Code (except during any period in which the
Transition Rule shall permit otherwise). 
 “Company” shall mean PharMEDium Healthcare Holdings, Inc., a Delaware
corporation and any successor thereto. 
 “Covered Employee” means any “covered employee” as defined in
Section 162(m) of the Code. 
 “Designation Period” shall mean, with respect to any Performance Period, a period
commencing on or before the first day of the Performance Period and ending not later than the earlier of (i) ninety (90) days after the commencement of the Performance Period and (ii) the date on which twenty-five
percent (25%) of the Performance Period has been completed. Any action required to be taken within a Designation Period may be taken at a later date if permissible under Section 162(m) of the Code. 







 “Participant” shall mean, for a Performance Period, (x) all
executive officers of the Company and (y) any other employee of the Company who is designated by the Committee to participate in the Plan within ninety (90) days following the commencement of the Performance Period (or such later
date, if any, as permitted under Code Section 162(m), including under the Transition Rule). 
 “Performance Period”
shall mean the fiscal year of the Company; provided, however, that the Committee may designate that the Performance Period for an Award be more than one fiscal year, or a portion of a fiscal year, or a pre-set continuous period that
does not correspond to the beginning or end of any fiscal year (in each case with any such designation by the Committee to be made within the time period permitted under Code Section 162(m)). 

“Plan” shall mean the PharMEDium Healthcare Holdings, Inc. Senior Executive Bonus Plan as set forth herein, as it may be
amended from time to time. 
 “Section 162(m) of the Code” means Section 162(m) of the Code, as amended from time to
time, and the applicable rules and regulations promulgated thereunder. 
 “Section 409A of the Code” means
Section 409A of the Code, as amended from time to time, and the applicable rules and regulations promulgated thereunder. 

“Subsidiary” shall mean any entity that is directly or indirectly controlled by the Company or any entity in which the
Company directly or indirectly has at least a 50% equity interest. 
 “Transition Rule” shall have the meaning set forth in
Section 5.1. 
 III. Administration 

3.1. General. The Plan shall be administered by the Committee, which shall have the full power and authority to interpret, construe and
administer the Plan and any Award granted hereunder (including reconciling any inconsistencies, correcting any defaults and addressing any omissions). The Committee’s interpretation, construction and administration of the Plan and all its
determinations hereunder shall be final, conclusive and binding on all persons for all purposes. 
 3.2. Powers and Responsibilities.
The Committee shall have the following discretionary powers, rights and responsibilities in addition to those described in Section 3.1: 

(a) to designate within the Designation Period the Participants for a Performance Period; 

(b) to determine the amounts of the Awards and any other material terms and conditions applicable to the Awards; 

(c) to decide whether, and under what circumstances and subject to what terms, Awards are to be paid on a deferred basis,
including whether such a deferred payment shall be made solely at the Committee’s discretion or whether a Participant may elect deferred payment, in each case, so long as such deferral or deferral election is permissible under, and complies,
with the requirements set forth in Section 409A of the Code 
 (d) to decide whether, and under what circumstances and
subject to what terms, Awards are to be settled in shares of common stock or other equity awards of the Company (provided, that any such equity awards shall be issued under the Company’s long-term equity incentive plan as in effect from
time to time), and the terms and conditions applicable to such awards, including without limitation vesting terms; and 

  
 2 








 (e) to adopt, revise, suspend, waive or repeal, when and as appropriate, in its
sole and absolute discretion, such administrative rules, guidelines and procedures for the Plan as it deems necessary or advisable to implement the terms and conditions of the Plan, so long as permitted under Section 162(m) of the Code. 

3.3. Delegation of Power. The Committee may delegate some or all of its power and authority hereunder to the Chief Executive Officer or
other executive officer of the Company as the Committee deems appropriate; provided, however, that with respect to any person who is a Covered Employee or who, in the Committee’s judgment, is likely to be a Covered Employee at any
time during the applicable Performance Period, only the Committee shall be permitted to (i) designate such person to participate in the Plan for such Performance Period, (ii) determine the amount of such person’s Award
for such Performance Period and (iii) take any other action required to be taken under Section 162(m) of the Code. Notwithstanding the foregoing, no Participant shall make decisions under the Plan with respect to his or her own
compensation under the Plan, including, without limitation, regarding his or her own Award. 
 3.4. Limitations on Discretion. It is
the intention that Awards under the Plan qualify as qualified performance-based compensation under Section 162(m) of the Code and that all payments made under the Plan be excluded from the deduction limitations contained in Section 162(m)
of the Code. The Plan shall be construed at all times in favor of its meeting the exception for qualified performance-based compensation contained in Section 162(m) of the Code. Accordingly, the Committee shall have no discretion under this
Plan (including, without limitation, with respect to adjustments to Adjusted EBITDA) if the actual exercise of such discretion or the ability to exercise such discretion would cause any Award to fail to qualify as qualified performance-based
compensation under Section 162(m) of the Code. Therefore, if any Plan provision is found not to be in compliance with the exception for qualified performance-based compensation, that provision shall be deemed amended so that the Plan does so
comply to the extent permitted by law and deemed advisable by the Committee. 
 IV. Awards 

4.1. Determination of Award Amounts. The maximum Award payable to any Participant individually under the Plan in respect of a
Performance Period shall not exceed five percent (5%) of the Company’s Adjusted EBITDA for the applicable Performance Period. The amount of each Participant’s Award for a Performance Period shall be determined by the Committee, acting
in its sole discretion subject to the maximum amount set forth above. For the avoidance of doubt, the Committee, acting in its sole discretion using whatever individual or corporate performance goals it determines to use, may determine to pay a
lesser amount with respect to an Award than the maximum amount specified herein. However, no Participant shall receive payment with respect to an Award unless Adjusted EBITDA in respect of the applicable Performance Period exceeds zero. To the
extent that Awards are expressed as a percentage of Adjusted EBITDA, the exercise of negative discretion with respect to one Participant shall not operate to result in an increase in payment to any other Participant. 

4.2. Timing of Payment. Any Award payment under the Plan shall be in cash and shall be paid as soon as practicable after the end of the
Performance Period, but no later than March 15 of the year immediately following the end of the fiscal year with which or in which the Performance Period ends. As conditions to the right of a Participant to receive an Award, (i) the
Committee shall first certify in writing the Company’s Adjusted EBITDA (which must be greater than zero) and that the Award has been determined in accordance with the provisions of the Plan and (ii) unless the Committee shall
determine otherwise (but consistent with Section 162(m) of the Code), such Participant must be employed by the Company on the payment date. 

  
 3 








 V. General 
  

	5.1.	Effective Date and Term of Plan. 

 (a) The Plan became effective upon the
effectiveness of the Company’s registration statement on Form S-1. The Plan shall be effective with respect to fiscal years of the Company beginning on or after January 1, 2015 and it will remain in effect until it is terminated by the
Committee. The Plan is intended to supplement the Company’s Management Incentive Compensation Plan with respect to the 2015 fiscal year of the Company (the “2015 Plan”). From and after the effective date of the Plan,
outstanding awards under the 2015 Plan shall be assumed into the Plan and treated as Awards under and governed by the terms of the Plan. It is intended that the Plan and the Awards shall qualify for the transition rule contained in Treas. Reg.
§1.162-27(f)(1) of the Code during the period set forth therein (the “Transition Rule”) and, during the period covered by such transition rule, shall be permitted to be administered consistent therewith notwithstanding any
provision of this Plan to the contrary. 
 (b) It is intended that the Plan shall be submitted to the Company’s
stockholders for approval not later than the annual meeting of stockholders to be held in the 2019 fiscal year of the Company. The effectiveness of the Plan with respect to the 2019 fiscal year of the Company is subject to such stockholder approval,
if not previously obtained. 
 5.2. Amendment and Termination. The Board or the Committee may at any time amend, suspend, discontinue
or terminate the Plan; provided, however, that no such action shall be effective without approval by the shareholders of the Company to the extent necessary to continue to qualify the amounts payable hereunder to Covered Employees as
performance-based compensation for purposes of Section 162(m) of the Code. 
 5.3. Non-Transferability of Awards. No Award under
the Plan shall be transferable other than by will, the laws of descent and distribution or pursuant to beneficiary designation procedures approved by the Company (including the procedures in Section 5.7, if applicable). Except to the extent
permitted by the foregoing sentence, no Award may be sold, transferred, assigned, pledged, hypothecated, encumbered or otherwise disposed of (whether by operation of law or otherwise) or be subject to execution, attachment or similar process. Upon
any attempt to sell, transfer, assign, pledge, hypothecate, encumber or otherwise dispose of any such Award, such Award and all rights thereunder shall immediately become null and void. 

5.4. Tax Withholding. The Company and each Subsidiary shall have the right and power to deduct from all amounts paid to a Participant
(whether under the Plan or otherwise) or to require a Participant to remit to the Company promptly upon notification of the amount due, an amount to satisfy the minimum federal, state or local or foreign taxes or other obligations required by law to
be withheld with respect thereto with respect to any Award. 
 5.5. Payment by a Subsidiary. The Company may satisfy its obligations
under the Plan with respect to a Participant by causing any Subsidiary to make the payment to which such Participant is entitled under the Plan. 

5.6. No Right of Participation or Employment. No person shall have any right to participate in the Plan. Neither the Plan nor any Award
shall confer upon any person any right to continued employment by the Company, any Subsidiary or any affiliate of the Company or affect in any manner the right of the Company, any Subsidiary or any affiliate of the Company to terminate the
employment of any person at any time without liability hereunder. 

  
 4 








 5.7. Designation of Beneficiary. If permitted by the Company, a Participant may file with
the Committee a written designation of one or more persons as such Participant’s beneficiary or beneficiaries (both primary and contingent) in the event of the Participant’s death. Each beneficiary designation shall become effective only
when filed in writing with the Committee during the Participant’s lifetime on a form prescribed by the Committee. The spouse of a married Participant domiciled in a community property jurisdiction shall join in any designation of a beneficiary
other than such spouse. The filing with the Committee of a new beneficiary designation shall cancel all previously filed beneficiary designations. If a Participant fails to designate a beneficiary, or if all designated beneficiaries of a Participant
predecease the Participant, then each outstanding Award shall be payable to the Participant’s executor, administrator, legal representative or similar person. 

5.8. Governing Law. The Plan and each Award, and all determinations made and actions taken pursuant thereto, to the extent not
otherwise governed by the Code or the laws of the United States, shall be governed by the laws of the State of Delaware and construed in accordance therewith without giving effect to principles of conflicts of laws. 

5.9. Other Plans. Award payments under the Plan shall not be treated as compensation for purposes of any other compensation or benefit
plan, program or arrangement of the Company or any of its Subsidiaries, unless either (i) such other plan provides compensation such as Award payments made pursuant to the Plan are to be considered as compensation thereunder or
(ii) the Board or the Committee so determines in writing. Neither the adoption of the Plan nor the submission of the Plan to the Company’s stockholders for their approval shall be construed as limiting the power of the Board or the
Committee to adopt such other cash- or equity-based incentive arrangements as it may otherwise deem appropriate. 
 5.10. Binding
Effect. The Plan shall be binding upon the Company and its successors and assigns and the Participants and their beneficiaries, personal representatives and heirs. If the Company becomes a party to any merger, consolidation or reorganization,
then the Plan shall remain in full force and effect as an obligation of the Company or its successors in interest, unless the Plan is amended or terminated pursuant to Section 5.2. 

5.11. Forfeiture of Awards under Applicable Laws or Regulations. Awards granted under the Plan shall be subject to clawback policies as
the Company may adopt or approve from time to time or as required by applicable law, regulation or stock exchange rule. Pursuant to such clawback policies, the Company may (i) cancel, reduce, or require a Participant to forfeit any Award
granted under the Plan or (ii) require a Participant to reimburse or disgorge to the Company any amounts received pursuant to the payment of an Award granted under the Plan, in each case, to the extent not prohibited by applicable law,
regulation or stock exchange rule in effect on or after the effective date of the Plan. 
 5.12. Unfunded Plan; Plan Not Subject to
ERISA. The Plan is an unfunded plan and Participants shall have the status of unsecured creditors of the Company. The Plan is not intended to be subject to the Employee Retirement Income and Security Act of 1974, as amended. 

5.13. Limitation Period for Claims. Any person who believes he or she is being denied any benefit or right under the Plan may file a
written notice with the Committee. Any claim must be delivered to the Committee within forty-five (45) days of the later of the payment date of the award or the specific event giving rise to the claim. Untimely claims will not be processed and
shall be deemed denied. The Committee will notify the Participant of its decision in writing as soon as administratively practicable. Claims not responded to by the Committee in writing within ninety (90) days of the date the written claim is
delivered to the Committee shall be deemed denied. The Committee’s decision is final and conclusive and binding on all persons. No lawsuit relating to the Plan may be filed before a written claim is filed with the Committee and is denied or
deemed denied and any lawsuit must be filed within one year of such denial or deemed denial or be forever barred. 

  
 5 








 5.14. 409A Compliance. The Plan is intended to provide for payments that are exempt from
the provisions of Section 409A of the Code to the maximum extent possible and otherwise to be administered in a manner consistent with the requirements, where applicable, of Section 409A of the Code. Where reasonably possible and
practicable, the Plan shall be administered in a manner to avoid the imposition on Participants of immediate tax recognition and additional taxes pursuant to Section 409A of the Code. Notwithstanding the foregoing, neither the Company nor the
Committee, nor any of the Company’s directors, officers or employees shall have any liability to any person in the event Section 409A of the Code applies to any payment or right under the Plan in a manner that results in adverse tax
consequences for the Participant or any of his beneficiaries or transferees. Notwithstanding any provision of the Plan to the contrary, the Board or the Committee may unilaterally amend, modify or terminate the Plan or any right hereunder if the
Board or Committee determines, in its sole discretion, that such amendment, modification or termination is necessary or advisable to comply with applicable U.S. law, as a result of changes in law or regulation or to avoid the imposition of an
additional tax, interest or penalty under Section 409A of the Code. 
 5.15. Severability. If any provision of the Plan is held
unenforceable, the remainder of the Plan shall continue in full force and effect without regard to such unenforceable provision and shall be applied as though the unenforceable provision were not contained in the Plan. 

  
 6